Dear colleagues and friends,
Thank you for attending the 2nd conference in the series Recent Advances in Rare Diseases – RARD: Frequently Misdiagnosed Hereditary Disorders (FREMIDIS) – Multidisciplinary Translational Research Affects Global Clinical Impact.
Over a period of three days, from May 3rd until May 5th 2018, at the RARD conference, 200 international experts, scientists and clinicians discussed and exchanged experiences, current research data and addressed the future development of new treatments for rare genetic disorders.
Given the complexity of rare diseases, the limited natural history data, and the smaller pool of patients to participate in clinical development, expert exchange is a necessary part towards the future of personalized medicine and orphan drug R&D. RARD conference addressed this issues by providing a unique network forum where the focus was to transform the worldwide science of genetic, clinical and R&D data into answers for the patients suffering from rare hereditary diseases.
RARD conference gathered an international audience and speakers from approximate 50 nationalities, and showcased the latest breakthroughs in genetics research and their applications to medical practice. The latest advances in the field of hereditary diseases were also communicated through a number of more than 40 posters presented at the conference.
The 2018 edition of RARD, Frequently Misdiagnosed Hereditary Disorders (FREMIDIS) – Multidisciplinary Translational Research Affects Global Clinical Impact, was a success and we want to thank you to all the participants and speakers for their dedication and commitment to help the rare hereditary disease patient community worldwide.
SCIENTIFIC ADVISORY COMMITTEE:
- Prof. Mia Horowitz /Israel
- Prof. Anil Jalan /India
- Prof. Elena Lukina /Russia
- Prof. Uma Ramaswami /UK
- Prof. Arndt Rolfs /Germany
- Prof. IC Verma /India
- Prof. Ari Zimran /Israel
RARD 2017 Moscow / Russia
The first meeting of the RARD series took place 18-20 May 2017 in Moscow/Russia with more than 250 participants from around the globe who discussed 3 days about “Recent advances in rare disease: Gaucher disease as a model (RARD 2017)”